PL1833508T3 - Szczepy świńskiego wirusa zespołu rozrodczo-oddechowego i ich kompozycje - Google Patents

Szczepy świńskiego wirusa zespołu rozrodczo-oddechowego i ich kompozycje

Info

Publication number
PL1833508T3
PL1833508T3 PL05851416T PL05851416T PL1833508T3 PL 1833508 T3 PL1833508 T3 PL 1833508T3 PL 05851416 T PL05851416 T PL 05851416T PL 05851416 T PL05851416 T PL 05851416T PL 1833508 T3 PL1833508 T3 PL 1833508T3
Authority
PL
Poland
Prior art keywords
respiratory syndrome
syndrome virus
porcine reproductive
compositions
virus strains
Prior art date
Application number
PL05851416T
Other languages
English (en)
Inventor
Richard Hesse
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of PL1833508T3 publication Critical patent/PL1833508T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10061—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL05851416T 2004-11-19 2005-11-09 Szczepy świńskiego wirusa zespołu rozrodczo-oddechowego i ich kompozycje PL1833508T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US62987304P 2004-11-19 2004-11-19
US67400205P 2005-04-21 2005-04-21
EP05851416A EP1833508B1 (en) 2004-11-19 2005-11-09 Porcine reproductive and respiratory syndrome virus strains and compositions
PCT/US2005/040366 WO2006055331A2 (en) 2004-11-19 2005-11-09 Porcine reproductive and respiratory syndrome virus strains and compositions

Publications (1)

Publication Number Publication Date
PL1833508T3 true PL1833508T3 (pl) 2011-02-28

Family

ID=36123980

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05851416T PL1833508T3 (pl) 2004-11-19 2005-11-09 Szczepy świńskiego wirusa zespołu rozrodczo-oddechowego i ich kompozycje

Country Status (14)

Country Link
US (1) US8178103B2 (pl)
EP (1) EP1833508B1 (pl)
JP (1) JP4750125B2 (pl)
KR (1) KR101152012B1 (pl)
CN (1) CN101084011B (pl)
AT (1) ATE479440T1 (pl)
AU (1) AU2005306781B2 (pl)
BR (1) BRPI0518353A2 (pl)
CA (1) CA2587849A1 (pl)
DE (1) DE602005023342D1 (pl)
DK (1) DK1833508T3 (pl)
MX (1) MX2007005968A (pl)
PL (1) PL1833508T3 (pl)
WO (1) WO2006055331A2 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008014391A (es) * 2006-05-12 2009-03-06 Bharat Biotech Int Ltd Una composicion util como vacuna.
CN100523177C (zh) * 2007-01-09 2009-08-05 中国农业科学院哈尔滨兽医研究所 猪繁殖与呼吸综合症病毒弱毒疫苗株及其应用
CN101307305B (zh) * 2008-04-30 2010-06-16 中国动物疫病预防控制中心 一种猪繁殖与呼吸综合征病毒弱毒株及免疫原性物质和疫苗
KR101345786B1 (ko) * 2010-09-09 2014-02-06 녹십자수의약품(주) 신규한 돼지생식기호흡기증후군 바이러스 및 그의 용도
UA108902C2 (uk) * 2010-11-10 2015-06-25 Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
ES2692809T3 (es) * 2011-02-17 2018-12-05 Boehringer Ingelheim Vetmedica Gmbh Nueva cepa del PRRSV europea
CN102321638B (zh) * 2011-09-06 2013-04-10 南京农业大学 一种新的猪繁殖与呼吸综合征病毒orf5修饰基因及其应用
KR101430223B1 (ko) * 2012-10-09 2014-09-25 전북대학교산학협력단 면역유도능이 증가된 돼지생식기호흡기증후군 바이러스
KR101502360B1 (ko) * 2013-03-20 2015-03-25 주식회사 옵티팜 신규한 국내형 돼지생식기호흡기증후군 바이러스
JP6484241B2 (ja) * 2013-12-03 2019-03-13 インターベット インターナショナル ベー． フェー． ＰＲＲＳおよびローソニア・イントラセルラリス（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）に対するブタワクチン
CN106924726B (zh) * 2015-12-29 2021-02-09 普莱柯生物工程股份有限公司 一种用于预防猪繁殖与呼吸综合征的疫苗组合物及其制备方法和应用
CN106039302A (zh) * 2016-06-21 2016-10-26 江苏省农业科学院 猪繁殖与呼吸综合征病毒核酸疫苗及其制备方法
JP6893765B2 (ja) * 2016-07-15 2021-06-23 森山　雅美 人以外の陸上動物用のウイルス感染症に対する抗体誘導剤とその補助剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165405T3 (es) * 1994-04-11 2002-03-16 Akzo Nobel Nv Cepas de vacuna europeas del virus del sindrome reproductor y respiratorio porcino (prrsv).
ES2102971B1 (es) * 1996-01-25 1998-03-01 Hipra Lab Sa Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion.
US5976537A (en) * 1996-07-02 1999-11-02 The United States Of America As Represented By The Secretary Of Agriculture Porcine reproductive and respiratory syndrome vaccine
PT835930E (pt) * 1996-10-09 2001-06-29 Akzo Nobel Nv Estirpes europeias de vacina do virus do sindroma reprodutivo e respiratorio porcino (prrsv)
ES2348159T3 (es) * 1999-04-22 2010-11-30 United States Department Of Agriculture Vacuna contra el sindrome respiratorio y reproductivo porcino basada en el aislado ja-142.
US6406460B1 (en) 2000-07-21 2002-06-18 Agecom, Inc. System and method for automatic needle change warning
EP1421184A2 (en) * 2001-03-09 2004-05-26 Boehringer Ingelheim Vetmedica Gmbh Live attenuated strains of prrs virus
ATE557082T1 (de) 2002-04-05 2012-05-15 Boehringer Ingelheim Vetmed Sequenz positionen zur anpassung bei prrsv

Also Published As

Publication number Publication date
BRPI0518353A2 (pt) 2008-11-18
CN101084011A (zh) 2007-12-05
MX2007005968A (es) 2007-07-20
AU2005306781A1 (en) 2006-05-26
KR20070086084A (ko) 2007-08-27
AU2005306781B2 (en) 2011-12-22
JP2008520238A (ja) 2008-06-19
ATE479440T1 (de) 2010-09-15
WO2006055331A3 (en) 2006-08-10
CN101084011B (zh) 2010-06-16
US8178103B2 (en) 2012-05-15
DE602005023342D1 (en) 2010-10-14
WO2006055331A9 (en) 2006-10-26
EP1833508B1 (en) 2010-09-01
EP1833508A2 (en) 2007-09-19
CA2587849A1 (en) 2006-05-26
JP4750125B2 (ja) 2011-08-17
DK1833508T3 (da) 2010-12-06
WO2006055331A2 (en) 2006-05-26
KR101152012B1 (ko) 2012-07-04
US20090238844A1 (en) 2009-09-24

Similar Documents

Publication Publication Date Title
WO2010025109A8 (en) Vaccine against highly pathogenic porcine reproductive and respiratory syndrome (hp prrs)
MX2007005968A (es) Cepas y composiciones del virus del sindrome reproductivo y respiratorio porcino.
UA86599C2 (en) Substituted benzimidazole-, benztriazole- and benzimidazolone-о-glucosides
SG156666A1 (en) Vaccines against japanese encephalitis virus and west nile virus
WO2005012242A3 (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
SG130189A1 (en) Substituted indole-o-glucosides
WO2007117303A3 (en) Combination vaccine comprising an attenuated bovine viral diarrhea virus
CL2008003813A1 (es) Circovirus porcino; molecula de acido nucleico que lo codifica; composicion inmunogenica que lo comprende; metodo para inmunizar un cerdo contra la infeccion virica o para prevenir el sindrome postdestete de desgaste multi-sistemico (pmsw);y metodo para determinar si un mamifero tiene o esta en riesgo de desarrollar pmsw.
SG159542A1 (en) Compositions against sars-coronavirus and uses thereof
MX2009004862A (es) Estabilizacion de vacunas por liofilizacion.
WO2005042767A3 (en) Compositions and methods for detecting severe acute respiratory syndrome coronavirus
UY31209A1 (es) Uso de homo y copolimeros para la estabilización de formulaciones de principios activos
MY152149A (en) Prevention and treatment of sub-clinical pcvd
DK1255815T3 (da) Porcint reproduktivt og respiratorisk syndromvirus til fremgangsmåder til anvendelse
TW200604343A (en) Cellular permissivity factor for viruses, and uses thereof
MX2007001035A (es) Metodo para producir una composicion, la composicion y su uso.
WO2006088481A3 (en) Genetically engineered equine influenza virus and uses thereof
TW200726479A (en) Method of inducing neutralizing antibodies to human immunodeficiency virus
TW200515917A (en) Methods and compositions for the generation of a protective immune response against SARS-COV
EP1794329A4 (en) ISOLATES OF PIG VIRUS CAUSING REPRODUCTION AND RESPIRATORY SYNDROME AND THEIR USE
MX2007006042A (es) Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion.
UA107177C2 (uk) Імуногенна композиція цвс2 та спосіб приготування такої композиції
UA95299C2 (ru) Профилактический или терапевтический агент против вирусного заболевания, вызванного вирусом гепатита с
MX2009005077A (es) Composicion absorbente para tratamiento de superficies.
GB0400774D0 (en) Pharmaceutical composition